23 results
425
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Business combination disclosure
5:12pm
of such Person under swaps, options, derivatives and other hedging agreements or arrangements that will be payable upon termination thereof (assuming
8-K
EX-2.1
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
5:10pm
owned Parent Subsidiary), or (vi) net cash payment obligations of such Person under swaps, options, derivatives and other hedging agreements
424B4
076t5o74msbi02ib
1 Apr 21
Prospectus supplement with pricing info
4:05pm
10-K
i014rvjbtrbok7vgkek
19 Mar 21
Annual report
4:11pm
DRS
2c6uhuj7
19 Mar 21
Draft registration statement
12:00am
8-K
EX-3.2
rwacc3nw7jgvykzz
9 Jun 20
Applied Molecular Transport Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
4:47pm
424B4
wgipa
5 Jun 20
Prospectus supplement with pricing info
4:52pm
S-1
EX-4.1
5ajs3o g6
18 May 20
IPO registration
4:03pm
S-1
p8hacte7cc
18 May 20
IPO registration
4:03pm
S-1
EX-10.2
uajw3prti eh7d
18 May 20
IPO registration
4:03pm
S-1
EX-10.3
iyt y5y4yhh86a3t1x
18 May 20
IPO registration
4:03pm
S-1
EX-3.4
72s 2fv6wxxv
18 May 20
IPO registration
4:03pm
DRS/A
68qc3r
10 Apr 20
Draft registration statement (amended)
12:00am
DRS
EX-10.3
abijgth9nl7 3l8k
13 Feb 20
Draft registration statement
12:00am